Cleared Traditional

K203336 - Thermo Scientific Oxoid Omadacycline Di...

K203336 is the FDA 510(k) clearance for Thermo Scientific Oxoid Omadacycline Di... by Oxoid Limited (Part of Thermo Fisher Scientific). It is a Class 2 Microbiology device (product code JTN) cleared through the Traditional 510(k) pathway after a 672-day FDA review.

K203336 · Oxoid Limited (Part of Thermo Fisher Scientific) · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2022
Decision
672d
Days
Class 2
Risk

K203336 is an FDA 510(k) clearance for the Thermo Scientific Oxoid Omadacycline Disc (30 ug) OMC30. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Oxoid Limited (Part of Thermo Fisher Scientific) (Basingstoke, GB). The FDA issued a Cleared decision on September 15, 2022 after a review of 672 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Oxoid Limited (Part of Thermo Fisher Scientific) devices

Submission Details

510(k) Number K203336 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 12, 2020
Decision Date September 15, 2022
Days to Decision 672 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
570d slower than avg
Panel avg: 102d · This submission: 672d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 282
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K203336.
BD BBL™ Sensi-Disc™ Lefamulin 20µg (LMU-20)
K230651 · Becton, Dickinson and Company · Jun 2023
HardyDisk AST Rezafungin 5µg (RZF5)
K230827 · Hardy Diagnostics · Jun 2023
BD BBL Sensi-Disc Cefiderocol 30ug (FDC-30)
K221826 · Becton, Dickinson and Company · Dec 2022
Thermo Scientific Oxoid Lefamulin Disc (20µg) LMU20
K210873 · Oxoid Limited (Part of Thermo Fisher Scientific) · Oct 2021
Thermo Scientific Oxoid Cefiderocol Disc (30 µg) FDC30
K203700 · Oxoid Limited (Part of Thermo Fisher Scientific) · Jul 2021
Thermo Scientific Oxoid Eravacycline Disc (20ug) ERV20
K193508 · Oxoid Limited (Part of Thermo Fisher Scientific) · Dec 2020